Clinical Trial Update: Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intraventricular fibrinolysis for aneurysmal subarachnoid hemorrhage, sponsored by University Hospital, Caen, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Snippet

Sponsor: University Hospital, Caen | Conditions: Subarachnoid Hemorrhage | Phase 3 | Status: TERMINATED